Literature DB >> 2207299

MODFIT: a pharmacokinetics computer program.

G D Allen1.   

Abstract

This paper presents a computer program, MODFIT, written in FORTRAN, primarily for use on the Digital Equipment Company VAX series computers for the mathematical analysis of concentration-time data. Drug data generated from biological fluids and tissues may be fitted by a variety of different models. For many models, parameter starting estimates are program generated prior to automatic nonlinear regression analysis using a modified Davidon-Fletcher-Powell algorithm. The output of results is extensive and plotting facilities are available. Explicit and differential equation models may be fitted to single dose data and simulations using all models (single or repeat dose) may be employed to generate drug concentration-time data with plotting output. The package has been tested on numerous data with no problems regarding local function minima. Some comparisons with existing programs have been made and MODFIT compares well with respect to robustness, efficiency, and ease of use.

Mesh:

Substances:

Year:  1990        PMID: 2207299     DOI: 10.1002/bdd.2510110603

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  18 in total

1.  A comparison of the pharmacokinetics of meropenem after intravenous administration by injection over 2, 3 and 5 minutes.

Authors:  H K Jones; H C Kelly; M Hutchison; R A Yates; F Ross; C Lomax; S Freestone; D Webb
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Jul-Sep       Impact factor: 2.441

2.  Effect of e-cigarette flavors on nicotine delivery and puffing topography: results from a randomized clinical trial of daily smokers.

Authors:  Natalie Voos; Danielle Smith; Lisa Kaiser; Martin C Mahoney; Clara M Bradizza; Lynn T Kozlowski; Neal L Benowitz; Richard J O'Connor; Maciej L Goniewicz
Journal:  Psychopharmacology (Berl)       Date:  2019-11-26       Impact factor: 4.530

3.  Harnessing Human Microphysiology Systems as Key Experimental Models for Quantitative Systems Pharmacology.

Authors:  D Lansing Taylor; Albert Gough; Mark E Schurdak; Lawrence Vernetti; Chakra S Chennubhotla; Daniel Lefever; Fen Pei; James R Faeder; Timothy R Lezon; Andrew M Stern; Ivet Bahar
Journal:  Handb Exp Pharmacol       Date:  2019

4.  Randomized within-subject trial to evaluate smokers' initial perceptions, subjective effects and nicotine delivery across six vaporized nicotine products.

Authors:  Natalie Voos; Lisa Kaiser; Martin C Mahoney; Clara M Bradizza; Lynn T Kozlowski; Neal L Benowitz; Richard J O'Connor; Maciej L Goniewicz
Journal:  Addiction       Date:  2019-04-25       Impact factor: 6.526

5.  Pharmacokinetics of meropenem in critically ill patients with acute renal failure treated by continuous hemodiafiltration.

Authors:  W A Krueger; T H Schroeder; M Hutchison; E Hoffmann; H J Dieterich; A Heininger; C Erley; A Wehrle; K Unertl
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

6.  Interspecies pharmacokinetics of a novel hematoregulatory peptide (SK&F 107647) in rats, dogs, and oncologic patients.

Authors:  D R Brocks; M I Freed; D E Martin; T S Sellers; N Mehdi; D R Citerone; V Boppana; B Levitt; B E Davies; J Nemunaitis; D K Jorkasky
Journal:  Pharm Res       Date:  1996-05       Impact factor: 4.200

7.  The pharmacokinetics of topotecan and its carboxylate form following separate intravenous administration to the dog.

Authors:  B E Davies; E A Minthorn; M J Dennis; H Rosing; J H Beijnen
Journal:  Pharm Res       Date:  1997-10       Impact factor: 4.200

8.  The tolerance to and pharmacokinetics of penciclovir (BRL 39,123A), a novel antiherpes agent, administered by intravenous infusion to healthy subjects.

Authors:  S E Fowles; D M Pierce; W T Prince; D Staniforth
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

9.  Pharmacokinetic studies and renal dehydropeptidase stability of the new beta-lactamase inhibitor BRL 42715 in animals.

Authors:  K Coleman; D R Griffin; P A Upshon
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

10.  Lack of a pharmacokinetic interaction between oral famciclovir and allopurinol in healthy volunteers.

Authors:  S E Fowles; S K Pratt; J Laroche; W T Prince
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.